GSK Save the Children Partnership

GSK Save the children GSK Save the children Copyright Ivy Lahon/Save the Children.

Partnership objectives

Save the Children is GSK’s global partner, delivering programs in 41 countries around the world.  The purpose of our shared value partnership – to help save one million children’s lives by tackling preventable mortality in children under five – aligns with Sustainable Development Goals 3 (Good Health and Wellbeing) and 17 (Partnerships for goals).  To date the partnership has reached over 4.6m people, including 2.6m children.

What are the health needs and challenges?

All programs address health infrastructure, access and education needs in countries in Africa, Asia, South and Central America, North America and Europe. Focus tends to be on women and children as there are the most vulnerable groups. Specific health needs are:

  • Family planning
  • Ante and post natal care
  • Malnutrition
  • Child vaccinations
  • Non communicable diseases (Asthma, COPD, diabetes, heart disease, cancer)
  • Communicable diseases (e.g. NTD’s including malaria, cholera)

Access to quality healthcare in underserved communities remains a key challenge globally. GSK programs with Save the Children aim to improve access to quality healthcare for the most underserved, whilst building a long-term, sustainable solution through educating communities on preventative health and accessing the health system, capacity building and advocacy.

Description of partnership activities and how they address needs and challenges

Specific areas of focus for our partnership are: improving access to basic healthcare – prevention and treatment – where the need is greatest; training and equipping health workers in the poorest communities; developing child friendly medicines with the potential to help save more lives; and working together and local and global levels to call for stronger child health policies and capacity building.  To date the partnership has reached over 4.6m people, including 2.6m children.  This global partnership has also created a step change in the speed at which GSK responds and help Save the Children’s emergency response to humanitarian crises and disaster relief.   This includes establishing an Emergency Health Unit to ensure a team of specialist health workers can be on the ground delivering basic healthcare within 72 hours as well as supporting Save the Children’s work for refugees in transit countries.

The partnership supports two flagship programs, one in the Democratic Republic of Congo, the other in Kenya, to tackle severe challenges in the supply of, and demand for, effective healthcare for mothers and babies.  Through these programs we aim to generate evidence and learning that can be replicated at scale.  These programs were created in conjunction with the respective Ministries of Health to help increase the likelihood that the model will continue locally and be scaled up nationally.

Partnership information

Company(ies) GlaxoSmithKline

Partner(s) Save the Children

Type of Partner(s) NGOs

Therapeutic Focus Non-Communicable Diseases, Neglected Tropical Diseases, Women and Children's Health, Vaccine-Preventable Diseases, Infectious Diseases

Disease(s) Asthma, Buruli Ulcer, Cancer, Cardiovascular Diseases, Chagas Disease, Children's Health, Cholera, Cysticercosis, Dengue, Diabetes, Dracunculiasis (Guinea Worm), Echinococcosis, Endemic Treponematoses (Yaws), Fascioliasis, Foodborne Trematodiases, Hepatitis, Human African Trypanosomiasis (Sleeping Sickness), Influenza, Leishmaniasis, Leprosy, Lymphatic Filariasis, Malaria, Malnutrition, Measles, Meningitis C, Mumps, Obstetrics, Onchocerciasis (River Blindness), Paratyphoid fever, Pneumonia, Podoconiosis, Polio, Respiratory Diseases, Rotavirus, Rubella, Schistosomiasis, Soil-Transmitted Helminthiasis, Trachoma, Women's Health

Targeted Population(s) Children, Marginalised / Indigenous People, Mothers, People with low income, Women


Start Date 2013

More information GSK Save the Children Partnership

Anticipated completion date Ongoing